SEC Form 4 · accession 0001554795-16-001000
IRIS BIOTECHNOLOGIES INC · IRSB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Simon Chin
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Dec 23, 2016
Accepted (ET)
Dec 30, 2016 · 4:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396238
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 23, 2016 | J | 320,500 | $0.13 | A | 13,001,063 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
$41,665 in salary paid in stock.